Piper Jaffray Says Arena Pharmaceuticals (ARNA) Sell-Off is an "Overreaction"
Tweet Send to a Friend
Piper Jaffray just issued some comments on Arena Pharmaceuticals (Nasdaq: ARNA), which is finding its shares under extreme pressure today ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE